<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(24)</volume><submitter>Goussault H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3-months of the first hospitalization for lung cancer in France.&lt;h4>Methods&lt;/h4>This analysis included patients with a first hospitalization for lung cancer (between January 1, 2016 and December 31, 2018) according to diagnosis-related groups entered into the French national medical-administrative database. Clinical and socioeconomic parameters and characteristics of that first hospitalization were analyzed. A model predictive of early mortality was developed based on those variables.&lt;h4>Results&lt;/h4>The 144,087 included patients were 67% men; median age of 68 [interquartile range 60-76] years; 47% had metastatic disease at diagnosis; and 34% and 23%, respectively, had received systemic treatment or undergone curative surgery. The 3-month mortality was 19%, and significantly higher for those ≥70 versus &lt;70 years old (OR 1.33, 1.22-1.45), men versus. women (OR 1.50, 1.44-1.55), those with metastatic disease at diagnosis (OR, 3.30, 3.18-3.43), first hospitalization via the emergency room (OR 1.65 1.59-1.71) and first hospitalization lasting >30 days (OR, 1.58 1.49-1.68). In contrast, no socioeconomic characteristic was associated with early mortality.&lt;h4>Conclusion&lt;/h4>Almost 1 in 5 patients diagnosed with lung cancer in France died within 3 months post-diagnosis. Improving survival requires diagnosis at an earlier stage and better organization of diagnosis and specific care pathways.</pubmed_abstract><journal>Cancer medicine</journal><pagination>5025-5034</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9761075</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Risk factors for early mortality of lung cancer patients in France: A nationwide analysis.</pubmed_title><pmcid>PMC9761075</pmcid><pubmed_authors>Epaud S</pubmed_authors><pubmed_authors>Chouaid C</pubmed_authors><pubmed_authors>Lazatti A</pubmed_authors><pubmed_authors>Algans C</pubmed_authors><pubmed_authors>Assie JB</pubmed_authors><pubmed_authors>Goussault H</pubmed_authors><pubmed_authors>Salaun-Penquer N</pubmed_authors><pubmed_authors>Rousseau M</pubmed_authors><pubmed_authors>Jung C</pubmed_authors><pubmed_authors>Gendarme S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk factors for early mortality of lung cancer patients in France: A nationwide analysis.</name><description>&lt;h4>Background&lt;/h4>Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3-months of the first hospitalization for lung cancer in France.&lt;h4>Methods&lt;/h4>This analysis included patients with a first hospitalization for lung cancer (between January 1, 2016 and December 31, 2018) according to diagnosis-related groups entered into the French national medical-administrative database. Clinical and socioeconomic parameters and characteristics of that first hospitalization were analyzed. A model predictive of early mortality was developed based on those variables.&lt;h4>Results&lt;/h4>The 144,087 included patients were 67% men; median age of 68 [interquartile range 60-76] years; 47% had metastatic disease at diagnosis; and 34% and 23%, respectively, had received systemic treatment or undergone curative surgery. The 3-month mortality was 19%, and significantly higher for those ≥70 versus &lt;70 years old (OR 1.33, 1.22-1.45), men versus. women (OR 1.50, 1.44-1.55), those with metastatic disease at diagnosis (OR, 3.30, 3.18-3.43), first hospitalization via the emergency room (OR 1.65 1.59-1.71) and first hospitalization lasting >30 days (OR, 1.58 1.49-1.68). In contrast, no socioeconomic characteristic was associated with early mortality.&lt;h4>Conclusion&lt;/h4>Almost 1 in 5 patients diagnosed with lung cancer in France died within 3 months post-diagnosis. Improving survival requires diagnosis at an earlier stage and better organization of diagnosis and specific care pathways.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-26T09:43:15.663Z</modification><creation>2025-04-06T13:09:13.159Z</creation></dates><accession>S-EPMC9761075</accession><cross_references><pubmed>35567378</pubmed><doi>10.1002/cam4.4821</doi></cross_references></HashMap>